In conclusion, our study demonstrated that the ZEB1-EPB41L5 axis is at the core of the mesenchymal program of breast cancer, which carries out ARF6-mediated invasion, metastasis and drug resistance. The gene discussed is EPB41L5; the disease is breast carcinoma.